Eli Lilly granted extended review period for arthritis drug
The FDA has extended the review period for Baricitnib, a new once-a-day drug for rheumatoid arthritis. Read More »
Health care economist: PBMs part of the drug cost solution
Dealing with the thorny, and often contentious, issue of drug prices is likely to be front and center in the early days of the new Trump administration. Arriving at a solution to curb increasing costs will be a delicate balance for all those with a stake in the issue, according to a leading health economist. Read More »
Major chains fill majority of Medicare Part D prescriptions
New data from the Centers for Medicare and Medicaid Services shows that major chain pharmacies such as CVS, Walgreens and Walmart account for over 79 percent of Prescription Drug Plans for the elderly. Read More »
Bill would help those in need access pharmacist-provided care
New legislation for Medicare Part B beneficiaries has recently been reintroduced to the Senate to give underserved communities access to pharmacist-provided care. Read More »
Data says older adults saved $5.6 billion on prescriptions last year
New data released by the Department of Health and Human Services shows that adults with disabilities on Medicare continue to save on prescriptions, and that there has been an increase in benefits from last year as a result of the Affordable Care Act. Read More »
FDA approves Teva pain medication for long-term use
The U.S. Food and Drug Administration has approved Vantrelatm, a pain medication designed by Teva Pharmaceutical Ltd., for long-term use in time-released capsules. Read More »
CVS Health plans drastic price cut on generic epi-pens
Following recent public reaction to the price of epinephrine auto-injector pens, known as “epi-pens,” and the desire for an affordable alternative, CVS Health intends to market authorized generic version two-packs for $109.99 apiece. Read More »
Study shows excessive use of acetaminophen can lead to hearing loss
A recent study has shown that using acetaminophen, an ingredient commonly found in painkillers, over a long period of time leads to an increased risk of hearing loss in adults. Read More »
Mylan CEO presents at annual health conference
Mylan CEO Heather Bresch presented at the 35th Annual J.P. Morgan Healthcare Conference in San Francisco. Read More »
European Commission OK's Gilead drug for Hepatitis C
The European Commission has granted Gilead Sciences Inc. marketing authorization for Vemlidy, a drug used in the treatment of people suffering from chronic Hepatitis B infections. Read More »
FDA approves application for new breast cancer treatment
The U.S. Food and Drug Administration recently approved a license application for Mylan Biotechnology, in collaboration with Biocon, for the use of biosimilar tratuzumab in the treatment of breast cancer. Read More »
Gilead Sciences awards $22 million in HIV research funds
Gilead Sciences Inc., has awarded more than $22 million in grants to help fund HIV cure programs. Read More »
Proposed CMS antimicrobial program hits delay with presidential transition
The Centers for Medicare and Medicaid Services hit a snag last week in seeking approval of a proposal that requires hospitals to have antimicrobial stewardship programs participating in Medicare and Medicaid programs. Read More »
Study seeks data on generic medication preferences
Results from a November study have raised concerns about how pharmacists substitute generic medications for their name brand counterparts. Read More »
Telecommunications can offer remote access to some health services
A new trend in communications is on the verge of creating a health care revolution, according to one rehabilitation clinic spokesperson. Read More »
CDC promotes pharmacists' role in helping patients with hypertension
The Centers for Disease Control and Prevention have released new resources to encourage pharmacists to take a more active role in the management of hypertension among their patients. Read More »
Ovarian cancer treatment receives FDA approval
Ovarian cancer patients who have a sensitivity to chemotherapy will soon have another option to treat their disease as the U.S. Food and Drug Administration has approved Avastin as an alternative to or supplement for chemotherapy. Read More »
Home care model increases patients' access while reducing costs
A recent study has shown that medical home care model as increased overall primary care of patients, and has reduced overall health care cost. Read More »
FDA approves review of Genentech drug to treat advanced bladder cancer
Biotech group Genentech scored a big victory as the U.S. Food and Drug Administration has granted a priority review of the company’s newest cancer-treating drug, Tecentriq. Read More »
Treatment for extrerme nearsightedness receives FDA approval
The U.S. Food and Drug Administration has approved the use of Lucentis, created by biotech company Genentech, for people suffering with severe nearsightedness. Read More »
Alerts Sign-up